Join to view full profile
1700 Luther LnPark Ridge, IL 60068
Phone+1 847-268-8200
Fax+1 847-410-0051
Dr. Bitran is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jacob Bitran is an oncologist in northern Illinois and is affiliated with City of Hope Cancer Center. He received his medical degree from University of Illinois College of Medicine and has been in practice 46 years. He specializes in hematologic oncology and is experienced in hematologic oncology and lymphoma & myeloma.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1977
Michael Reese Hospital/University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1975
Rush University Medical CenterResidency, Pathology-Anatomic and Clinical, 1972 - 1973- Michael Reese Hospital/University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 1971 - 1972
University of Illinois College of MedicineClass of 1971
Certifications & Licensure
CA State Medical License 1976 - Present
IL State Medical License 1972 - 2029
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2012, 2014, 2016-2017
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Dec 10
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Feb 28
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Feb 08
Publications & Presentations
PubMed
- 2 citationsNivolumab-Induced Hemophagocytic Lymphohistiocytosis (HLH) in a Patient With Metastatic Melanoma: A Case Report and Literature Review.Ravjot K Virdi, Umar Hussain, Jacob Bitran
Cureus. 2025-10-01 - 6 citationsAdvances in Therapy of Adult Patients with Acute Lymphoblastic Leukemia.Oscar Sucre, Saagar Pamulapati, Zeeshan Muzammil, Jacob Bitran
Cells. 2025-03-04 - T-Cell Lymphoproliferative Disorders Following Allogeneic Bone Marrow Transplant: A Report of Two Cases and a Literature Review.Nicholas Prabhakar, Harrah Chiang, Irma Munoz Verdugo, Ari Hakimian, Shams Bufalino
Cureus. 2024-05-01
Authored Content
- A Retrospective Study of Double-Hit Lymphomas in Elderly Patients (> 70 Years): Overall OutcomesFebruary 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: